Dois-je éviter 3-benzylidene camphor pendant la grossesse ? | VeriMom
Authoritative safety review (SCCS, 2013) found multiple in vitro hormonal activities (estrogenic, anti‑estrogenic and anti‑androgenic) and in vivo changes in hormone‑responsive gene expression; SCCS concluded use as a UV filter up to 2% was not safe. ECHA has listed 3‑benzylidene camphor on the REACH Candidate List as an SVHC for endocrine‑disrupting properties and the ingredient is subject to cosmetic prohibitions in EU Annex II. Taken together this supports 'suspected' reproductive/fetal hazard (H=2), demonstrated hormonal mechanisms (M=2) and measurable systemic exposure from topical use (E=2).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- 3-benzylidene camphor est-il sûr pendant la grossesse ?
- Authoritative safety review (SCCS, 2013) found multiple in vitro hormonal activities (estrogenic, anti‑estrogenic and anti‑androgenic) and in vivo changes in hormone‑responsive gene expression; SCCS concluded use as a UV filter up to 2% was not safe. ECHA has listed 3‑benzylidene camphor on the REACH Candidate List as an SVHC for endocrine‑disrupting properties and the ingredient is subject to cosmetic prohibitions in EU Annex II. Taken together this supports 'suspected' reproductive/fetal hazard (H=2), demonstrated hormonal mechanisms (M=2) and measurable systemic exposure from topical use (E=2).
- 3-benzylidene camphor est-il sûr pendant l'allaitement ?
- Same hazard/mechanistic evidence applies (endocrine activity, SCCS concerns; ECHA SVHC listing). Topical cosmetic application can produce measurable systemic levels for lipophilic UV‑filter type compounds, so moderate exposure to the nursing parent (and potential low‑to‑moderate transfer to milk) is plausible though direct milk‑transfer data are lacking; therefore exposure scored as moderate (E=2).
- 3-benzylidene camphor est-il sûr pour la peau de bébé ?
- Hazard and mechanism as above (SCCS: endocrine activity; ECHA: SVHC for endocrine disruption). Because infants 0–3 years have an immature skin barrier and higher surface‑area‑to‑body‑weight, exposure score is increased by +1 relative to adult topical exposure (adult E=2 → infant E=3). Infants may therefore be at higher internal exposure and greater sensitivity to hormonal perturbation.
- Comment VeriMom évalue-t-il 3-benzylidene camphor ?
- VeriMom évalue 3-benzylidene camphor à 13/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à 3-benzylidene camphor pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à 3-benzylidene camphor basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.